New treatments for comorbidities after diagnosis with multiple sclerosis (MS): A study in the UK clinical practice research datalink (CPRD) GOLD

被引:0
|
作者
Persson, Rebecca [1 ]
Lee, Sally [2 ]
Minton, Neil [2 ]
Niemcryk, Steve [2 ]
Lindholm, Anders [2 ]
Jick, Susan [1 ,3 ]
机构
[1] Boston Collaborat Drug Surveillance Program, Lexington, MA USA
[2] Celgene Corp, Summit, NJ USA
[3] Boston Univ, Sch Publ Hlth, Boston, MA USA
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
570
引用
收藏
页码:279 / 280
页数:2
相关论文
共 50 条
  • [1] Increased risk of comorbidities in patients before as well as after multiple sclerosis (MS) diagnosis: a study in the UK Clinical Practice Research Datalink (CPRD).
    Jick, S.
    Persson, R.
    Lee, S.
    Minton, N.
    Niemcryk, S.
    Lindholm, A.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 53 - 54
  • [2] Suicidal behaviors in patients diagnosed with multiple sclerosis (MS): A study in the UK clinical practice research datalink (CPRD) GOLD
    Persson, Rebecca
    Lee, Sally
    Minton, Neil
    Niemcryk, Steve
    Lindholm, Anders
    Jick, Susan
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 98 - 98
  • [3] Primary Sclerosing Cholangitis in the UK Clinical Practice Research Datalink (CPRD GOLD)
    Liang, Huifang
    Lin, Jennifer H.
    Shick, Jesse
    Manne, Sudhakar
    Bharania, Punam
    Dolin, Paul
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 378 - 378
  • [4] Natural History Of Primary Sclerosing Cholangitis - A Study Using the UK Clinical Practice Research Datalink (CPRD GOLD)
    Liang, Huifang
    Manne, Sudhakar
    Shick, Jesse
    Bharania, Punam
    Dolin, Paul
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 115 - 115
  • [5] Prodromal symptoms of multiple sclerosis in primary care: a case-control study using the UK Clinical Practice Research Datalink (CPRD)
    Disanto, G.
    MacLachlan, S.
    Zecca, C.
    Handunnetthi, L.
    Sacco, R.
    Meier, U.
    Benkert, P.
    Simpson, A.
    McDonald, L.
    Rossi, A.
    Kuhle, J.
    Ramagopalan, S. V.
    Gobbi, C.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 456 - 457
  • [6] The Prescribing of Simvastatin in the UK - A Drug Utilisation Study in the Clinical Practice Research Datalink (CPRD)
    Allen, Craig
    Donegan, Katherine L.
    Thomson, Andrew
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 453 - 453
  • [7] GOLD assessment of COPD severity in the Clinical Practice Research Datalink (CPRD)
    Rebordosa, Cristina
    Plana, Estel
    Aguado, Jaume
    Thomas, Steven
    Garcia-Gil, Esther
    Perez-Gutthann, Susana
    Castellsague, Jordi
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 (02) : 126 - 133
  • [8] Increased risk of infections in patients diagnosed with multiple sclerosis (MS): a study in the UK Clinical Practice Research Database (CPRD)
    Jick, S.
    Persson, R.
    Lee, S.
    Minton, N.
    Niemcryk, S.
    Lindholm, A.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 581 - 581
  • [9] Cardiovascular disease (CVD) in patients diagnosed with multiple sclerosis (MS): a study in the UK Clinical Practice Research Database (CPRD)
    Jick, S.
    Persson, R.
    Lee, S.
    Minton, N.
    Niemcryk, S.
    Lindholm, A.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 375 - 376
  • [10] Cluster Headache Diagnosis and Treatment in the Clinical Practice Research Datalink (CPRD)
    Flahavan, Evelyn M.
    Jones, Meghan E.
    Mitchell, Lucy
    Swain, Jonathan L.
    Martinez, James M.
    Ahn, Andrew H.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 101 - 101